Latest News

Oral anticancer agents are being launched at significantly higher prices compared with a decade ago, which can prove a barrier to patient access, according to a new analysis published in JAMA Oncology.
Our peer-reviewed research, featured recently in healthcare and mainstream news reports.
This sweeping proposal is the biggest step yet in shifting reimbursement from a volume-based to a value-based system. Stakeholders offered mixed opinions this week.
What We’re Reading, April 29, 2016: While sales of Gilead's Harvoni drop, NY state attorney's decision could be good news for the company; and the FDA faces a lawsuit from a consumer advocacy group.
Dr Steven Pearson on Analyzing the Long-Term Benefits of New Drugs
When pricing new drugs, it’s difficult to understand how their performance will play out in the long term, and for that reason, Institute for Clinical and Economic Review (ICER) has created models that predict future costs and benefits, said Steven Pearson, MD, MSc, FRCP, founder and president of ICER.
Overall use of a web-based tool providing real-time, personalized episode-level price estimates for healthcare was low, but for some procedures the number of people searching for prices of services was high relative to the number of people who received the service.
A small study in 30 patients with advanced B-cell acute lymphoblastic leukemia has further strengthened the faith in the potential of chimeric antigen receptor or CAR-T cell therapy.
Unlike its closest rival, CVS Health, Express Scripts does not have a retail healthcare delivery infrastructure.
One leading expert called the proposal the most substantive change in decades, but some feared CMS is once again hastening the demise of the independent physician.
A company in Canada, Biolyse Pharma, has offered to manufacture a generic version of enzalutamide at a significantly lower price than what CMS paid in 2014.
Dr Sophia Smith Highlights the Importance of Patient-Reported Outcomes
Listening to patient-reported outcomes, especially in clinical trials, is extremely important, especially the array of technology available to collect this information, said Sophia K. Smith, PhD, MSW, associate professor at the Duke School of Nursing.
What we're reading, April 28, 2016: Valeant officials express remorse over price hikes of heart drugs; Paul Ryan proposes placing consumers with serious medical conditions in high-risk pools; and a British medical organization is urging smokers to switch to e-cigarettes.
Patients whose hospital care providers used mobile secure text messaging to communicate had shorter hospital stays compared with patients whose health providers used standard paging systems to communicate.
A collaboration between the Dana-Farber Cancer Institute and the fitness tracking company Fitbit will investigate whether weight loss in women diagnosed with breast cancer can stave off recurrence.

From the Journals

An analysis of the largest cohort available reveals that youths with type 1 diabetes, on a Medicaid managed care plan, are less likely to be readmitted within 90 days of discharge.
Coverage of sessions held at Cancerscape, the Association of Community Cancer Center’s 42nd annual meeting on policy, value, and quality, held March 2-4, 2016, in Washington, DC.
This study analyzes the effect of a managed care program on Medicaid expenditures for children with special healthcare needs using a quasi-experimental design.
While clinical pathways can help standardize care, considering the multitude of options available for oncology care providers, there is significant push-back from providers as well.
Evidence-Based Oncology invited a panel of experts who are experienced in the creation of oncology care pathways, use them in their practice, and have researched the development and implementation of care pathways, to exchange ideas on the topic.
Despite the fundamental advances in cancer care technology and care delivery that have made these improvements possible, our delivery system remains quite inefficient and frequently falls short of being truly patient-centered. Is a system-based solution the answer?
This study evaluated the impact of a patient safety intervention and national guideline to reduce unnecessary red blood cell transfusions in a large, urban academic medical center.
An opportunity exists to better understand healthcare utilization patterns by low-income workers, which may contribute significantly to employer healthcare cost trend and lost workforce productivity.
Single-tablet regimens are associated with higher adherence rates, decreased hospitalizations, and a higher proportion of patients with undetectable viral load compared with multiple-tablet regimens in patients with HIV/AIDS.
Featured Content
Diabetes Compendium
Oncology Compendium
Reimbursement Compendium
HF Compendium

Most Popular

Upcoming Partner Events
August 17-18, 2016
Philadelphia, PA
August 23-24, 2016
Chicago, IL
October 19-20, 2016
Scottsdale, AZ

AJMC Strategic Alliance